IRCCS Institute of Neurological Sciences, Via Altura 3, 40139, Bologna, Italy,
Neurol Sci. 2014 Jul;35(7):1053-8. doi: 10.1007/s10072-014-1642-7. Epub 2014 Jan 30.
Dystonia is a disabling and disfiguring disorder that can often affect many aspects of patients' daily lives, and lower their self-esteem. To date, quality of life (QoL) has been assessed in dystonic patients using generic measures that do not address the specific problems of this diagnostic group. Recently, two disease-specific scales "The Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)" were validated for measuring QoL in craniocervical dystonia patients. No disease-specific scales for QoL for dystonic patients are currently available in Italian. The aim of our study was to produce and validate the Italian version of the CDIP-58 and CDQ-24. We obtained the Italian version of CDQ-24 and CDIP-58 with a back-translation design. Both scales were applied to a population of 94 craniocervical dystonia patients along with the Short Form 36 health-survey questionnaire (SF-36), both before and 4 weeks after botulinum toxin therapy. A group of 65 controls matched for sex, age and comorbidity underwent the SF-36. Internal consistency was satisfactory for all subscales. Both the CDIP-58 and CDQ-24 showed moderate to high correlations with similar items of the SF-36. Sensitivity to change was confirmed by highly significant improvements in all CDQ-24 subscales and by moderate improvements in three out of eight CDIP-58 subscales and total score. This is the first Italian study on QoL in dystonia patients. We validated the Italian version of two disease-specific questionnaires to evaluate QoL in craniocervical dystonia patients. These scales could be useful for both clinical practice and clinical trials.
肌张力障碍是一种使人丧失能力且使人毁容的疾病,它常常会影响患者日常生活的许多方面,并降低他们的自尊心。迄今为止,人们使用通用的评估方法来评估肌张力障碍患者的生活质量(QoL),这些方法无法解决该诊断组的具体问题。最近,两种疾病特异性量表“颈肌张力障碍影响量表(CDIP-58)”和“颅颈肌张力障碍问卷(CDQ-24)”已被验证可用于测量颅颈肌张力障碍患者的 QoL。目前,尚无针对意大利语的肌张力障碍患者的特定疾病 QoL 量表。我们的研究旨在制作和验证 CDIP-58 和 CDQ-24 的意大利语版本。我们使用反向翻译设计获得了 CDQ-24 和 CDIP-58 的意大利语版本。这两个量表均应用于 94 例颅颈肌张力障碍患者,以及使用肉毒杆菌毒素治疗前后的简短形式 36 健康调查问卷(SF-36)。一组 65 名性别、年龄和合并症相匹配的对照组接受了 SF-36 测试。所有子量表的内部一致性均令人满意。CDIP-58 和 CDQ-24 与 SF-36 的相似项目均显示出中度至高度相关性。CDQ-24 的所有子量表以及 CDIP-58 的三个子量表和总分均显示出显著的变化敏感性,表明所有量表均具有较高的敏感性。这是意大利语肌张力障碍患者 QoL 的第一项研究。我们验证了两种疾病特异性问卷的意大利语版本,以评估颅颈肌张力障碍患者的 QoL。这些量表在临床实践和临床试验中都可能有用。